01 1PROCOS SpA
01 1Methyl Aminolevulinate Hydrochloride
01 1Italy
METHYL AMINOLEVULINATE HYDROCHLORIDE
NDC Package Code : 46016-7940
Start Marketing Date : 2021-11-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
A METHYL AMINOLEVULINATE HYDROCHLORIDE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of METHYL AMINOLEVULINATE HYDROCHLORIDE, including repackagers and relabelers. The FDA regulates METHYL AMINOLEVULINATE HYDROCHLORIDE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. METHYL AMINOLEVULINATE HYDROCHLORIDE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A METHYL AMINOLEVULINATE HYDROCHLORIDE supplier is an individual or a company that provides METHYL AMINOLEVULINATE HYDROCHLORIDE active pharmaceutical ingredient (API) or METHYL AMINOLEVULINATE HYDROCHLORIDE finished formulations upon request. The METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers may include METHYL AMINOLEVULINATE HYDROCHLORIDE API manufacturers, exporters, distributors and traders.
click here to find a list of METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing METHYL AMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for METHYL AMINOLEVULINATE HYDROCHLORIDE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture METHYL AMINOLEVULINATE HYDROCHLORIDE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain METHYL AMINOLEVULINATE HYDROCHLORIDE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a METHYL AMINOLEVULINATE HYDROCHLORIDE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of METHYL AMINOLEVULINATE HYDROCHLORIDE suppliers with NDC on PharmaCompass.
We have 1 companies offering METHYL AMINOLEVULINATE HYDROCHLORIDE
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
